Tag:
Nitec Pharma
Latest Headlines
Latest Headlines
Buzz: Horizon closing in on deal to buy Nitec Pharma
Bloomberg reports this morning that Horizon Therapeutics, which develops combo pain therapies, is closing in on a deal to buy Nitec Pharma AG in Switzerland. Sources tell the business news service
Nitec trumpets successful late-stage RA trial
Switzerland's Nitec Pharma says its new rheumatoid arthritis drug Lodotra posted positive results in a second late-stage trial. And armed with a stack of trial data, the developer says it is now
Link Medicine pockets $40M in third venture round
Despite all the market turmoil, there are a slew of new investment rounds to report this morning. It may be getting harder to raise venture capital, but Cambridge, MA-based Link Medicine nevertheless
